A Comparison of the Efficacy of Cisatracurium and Atracurium in Kidney Transplantation Operation

Journal of the Medical Association of Thailand

Volumn 87, Issue 1, 2004, Pages 73-79

  Jirasiritham, Siriwan ^a   Tantivitayatan, Kamthorn ^a   Jirasiritham, Sopon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Atracurium; Cisatracurium; Kidney Transplantation

Indexed keywords

ATRACURIUM; CALCIUM CHANNEL BLOCKING AGENT; CISATRACURIUM; ETILEFRINE; FENTANYL; ISOFLURANE; MUSCLE RELAXANT AGENT; NIFEDIPINE; NITROGEN DIOXIDE; OXYGEN; THIOPENTAL; DRUG DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST CONTROL; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MAINTENANCE DRUG DOSE; MALE; MUSCLE RELAXATION; SIBLING; ANESTHESIA; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANESTHESIA; ATRACURIUM; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; TREATMENT OUTCOME;

EID: 1542348636     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Meistelman C. Update on neuromuscular pharmacology. Curr Opin Anesthesiol 2001; 14: 399-404.
2. Wastila W, Maehr RB, LaMunion GL, Belmont MR, Savarese JJ. Preclinical pharmacology of cisatracurium besylate. Curr Opin Anesthesiol 1996; 9: S2-S8.
3. Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR. Importance of the organ-independent elimination of cisatracurium. Anesth Analg 1996; 83: 1065-71.
4. 2-opioid anesthesia. Anesth Analg 1996; 83: 823-9.
5. Efficacy and pharmacodynamics. Nimbex Technical Monograph.
6. Konstadt SN, Reich DL, Stanley TE, et al. A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex™) and vecuronium in patients with coronary artery disease. Anesth Analg 1995; 81: 1010-4.
7. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311: 1145-8.
8. Anaizi N. Drug dosing in patients with renal insufficiency. The Drug Monitor. http://www.home.eznet. net/~webtent/disclaimer.html Last update 7/7/2001.
9. DeWolf AM, Freeman JA, Scott VL, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 1996; 76: 624-8.
10. Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Diaz J, Wolf KB. Pharmacodynamics and pharmacokinetics in geriatric surgical patients. Anesthesiology 1996; 84: 520-5.
11. Boyd AH, Eastwood NB, Parker CJ, Hunter JM. Pharmacodynamics of IR cis-1′R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 1995; 74: 400-4.
12. Mosby Drug Consult @ 2003 http://home.mdconsult. com/das/drug/body/188350313/1/335.html #D000335.
13. Veien M, Szlam F, Holden JT, Yamaguchi K, Denson DD, Levy JH. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000; 92: 1074-81.
14. El-Sanabary M, El-Hefnawy S, Sarhan MS, Niazy A. Pharmacodynamic profile, systemic and pulmonary hemodynamic effects of atracurium and cisatracurium in children with cyanotic congenital heart disease. Eg J Anesth 2002; 18: 29-36.
15. Soukup J, Doenicke A, Hoernecke R, Vorhammer B, Seebauer A, Moss J. Cardiovascular effects after bolus application of cisatracurium. A comparison with vecuronium. Der Anaesthesist 1996; 45: 1024-9.
16. Krombach J, Hunzelmann N, Koster F, Bischoff A, Hofmann-Menzel H, Buzello W. Anaphylactoid reactions after cisatracurium administration in six patients. Anesth Analg 2001; 93: 1257-9.
17. Chiu JW, White PF. The pharmacoeconomics of neuromuscular blocking drugs [Rapacuronium]. Anesth Analg 2000; 90: S19-23.